Показано 0 из 0
Дата |
---|
09.02.2024 |
08.02.2024 |
07.02.2024 |
06.02.2024 |
05.02.2024 |
02.02.2024 |
01.02.2024 |
31.01.2024 |
30.01.2024 |
29.01.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
28.88
|
29.04
|
28.73
|
28.73
|
28.89
|
28.88
|
|
|
|
|
28.88
|
29.07
|
27.20
|
27.20
|
28.97
|
28.89
|
|
|
|
|
27.35
|
27.53
|
27.21
|
27.18
|
27.39
|
27.39
|
|
|
|
|
27.33
|
27.52
|
27.04
|
27.04
|
27.38
|
27.38
|
|
|
|
|
27.22
|
27.40
|
26.90
|
26.88
|
27.25
|
27.25
|
|
|
|
|
27.03
|
27.22
|
26.80
|
26.76
|
27.15
|
27.15
|
|
|
|
|
26.91
|
27.10
|
26.90
|
26.90
|
27.08
|
26.97
|
|
|
|
|
27.10
|
27.28
|
26.96
|
26.96
|
27.02
|
27.01
|
|
|
|
|
27.03
|
27.22
|
27.04
|
27.00
|
27.07
|
27.07
|
|
|
|
|
27.09
|
27.27
|
27.02
|
27.02
|
27.26
|
27.17
|
|
|
|
|
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.